83 related articles for article (PubMed ID: 16490049)
1. Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset.
Spalletta G; Bernardini S; Bellincampi L; Federici G; Trequattrini A; Caltagirone C
Eur J Neurol; 2006 Feb; 13(2):176-82. PubMed ID: 16490049
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
4. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
5. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
7. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
Davidson Y; Gibbons L; Purandare N; Byrne J; Hardicre J; Wren J; Payton A; Pendleton N; Horan M; Burns A; Mann DM
Dement Geriatr Cogn Disord; 2006; 22(1):15-9. PubMed ID: 16645276
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
11. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
[TBL] [Abstract][Full Text] [Related]
13. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.
Stern Y; Brandt J; Albert M; Jacobs DM; Liu X; Bell K; Marder K; Sano M; Albert S; Del-Castillo Castenada C; Bylsma F; Tycko B; Mayeux R
Ann Neurol; 1997 May; 41(5):615-20. PubMed ID: 9153523
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
Feldman B; Chapman J; Korczyn AD
Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
17. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Qian W; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
[TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
[TBL] [Abstract][Full Text] [Related]
19. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
20. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]